文献速递关节外科

全膝关节置换术中止血带使用是否影响五年结局

Does the Use of a Tourniquet Influence Five-Year Outcomes Following Total Knee Arthroplasty?
PubMed 文献 · J Arthroplasty · 2024-11-16

该研究为一项随机对照试验的事后分析,纳入227例初次全膝关节置换患者,比较止血带组(112例)与无止血带组(115例)的临床与患者报告结局。结果显示两组在失血量、手术时间、疼痛评分、住院时间、出院回家率、90天再入院、5年翻修率及假体生存率等方面均无显著差异,作者认为止血带使用可由外科医生自行决定。

要点

  • 止血带组与无止血带组在5年全因翻修率(3.6% vs 5.2%,P=0.546)和无菌假体生存率(P=0.769)上无显著差异。
  • 两组在术后3个月、1年及5年的KOOS-JR、PROMIS疼痛强度、疼痛干扰及身体健康评分上均无显著差异。
  • 止血带组失血量(131.8 vs 116.7 mL,P=0.098)和手术时间(97.8 vs 95.7分钟,P=0.264)有减少趋势但未达统计学显著。

核心结论

  • 初次全膝关节置换术中使用止血带与长达5年随访的临床或患者报告结局无差异相关。
  • 作者认为全膝关节置换术中止血带使用可由外科医生自行决定。

研究设计与样本

  • 该研究为一项随机对照试验的事后分析,纳入227例接受初次全膝关节置换的患者。
  • 患者分为止血带组(n=112)和无止血带组(n=115),比较两组临床结局和患者报告结局指标。
  • 证据等级为III级。

主要发现

  • 止血带组与无止血带组相比,失血量有减少趋势(131.8 vs 116.7 mL,P=0.098),手术时间有缩短趋势(97.8 vs 95.7分钟,P=0.264),均未达统计学显著。
  • 止血带组术后第一天视觉模拟量表疼痛评分略高(3.1 vs 3.6,P=0.197),住院时间(2.0 vs 2.1天,P=0.837)和出院回家率(88.7% vs 92.0%,P=0.340)相当。
  • 无止血带组发生3例90天再入院,止血带组无再入院(2.7% vs 0%,P=0.081)。
  • 末次随访时两组主动活动度相似(108.3 vs 106.5度,P=0.457)。
  • 5年全因翻修率在无止血带组与止血带组间相当(5.2% vs 3.6%,P=0.546),Kaplan-Meier生存分析显示5年无菌假体生存率相当(P=0.769)。

临床怎么用

  • 作者认为,初次全膝关节置换术中止血带的使用可由外科医生自行决定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A tourniquet is commonly used during total knee arthroplasty (TKA) to improve surgical field visibility and minimize blood loss. While the short-term effects of tourniquet use on postoperative outcomes have been studied extensively and found to be minimal, its influence on longer-term outcomes remains underexplored. This study examined tourniquet use in TKA with up to 5-year follow-up. METHODS: In this post hoc analysis of a randomized controlled trial, 227 patients who underwent primary TKA in the tourniquet (T) group (n = 112) or no tourniquet (NT) group (n = 115) were evaluated. Clinical outcomes and patient-reported outcome measures were compared between the two groups. RESULTS: The T group had non-significant trends toward reduced blood loss (131.8 versus 116.7 mL, P = 0.098) and shorter operative time (97.8 versus 95.7 minutes, P = 0.264), with slightly higher postoperative day one visual analog scale pain scores (3.1 versus 3.6, P = 0.197). Length of stay (2.0 versus 2.1 days, P = 0.837) and home discharge rate (88.7 versus 92.0%, P = 0.340) were comparable. The NT group had 3 90-day readmissions, while none occurred in the T group (2.7 versus 0%, P = 0.081). The active range of motion at the final follow-up was similar between groups (108.3 versus 106.5 degrees, P = 0.457). All-cause revision rates at 5 years were comparable between the NT and T groups (5.2 versus 3.6%, P = 0.546). Kaplan-Meier survivorship analysis revealed comparable aseptic implant survival at 5 years (P = 0.769). There were no significant differences in Knee injury and Osteoarthritis Outcome Score for Joint Replacement, Patient-Reported Outcomes Measurement Information System (PROMIS) pain intensity, PROMIS pain interference, or PROMIS physical health scores at 3 months, 1 year, and 5 years postoperatively. CONCLUSIONS: Using a tourniquet during primary TKA was not associated with differences in clinical or patient-reported outcomes at up to 5-year follow-up. These findings suggest that tourniquet use in TKA can be left to the surgeon's discretion. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Katzman JL, Sandoval CG, Roof MA, et al. Does the Use of a Tourniquet Influence Five-Year Outcomes Following Total Knee Arthroplasty? J Arthroplasty. 2024. PMID: 39557227. doi:10.1016/j.arth.2024.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。